David B. Nash is the Founding Dean Emeritus, and he remains on the full-time faculty as the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy, at the Jefferson College of Population Health (JCPH). His 11 year tenure as Dean completes more than 32 years on the University faculty. JCPH is dedicated to developing healthcare leaders for the future.
A board-certified internist, Dr. Nash is internationally recognized for his work in public accountability for outcomes, physician leadership development, and quality-of-care improvement. More recently, he has achieved wide acclaim for his Covid19 thought leadership and served as the Chief Health Advisor for the Philadelphia Convention and Visitor’s Bureau (PHL-CVB) for the duration of the pandemic.

Repeatedly named to Modern Healthcare’s list of Most Powerful Persons in Healthcare, his national activities cover a wide scope. Dr. Nash is a principal faculty member for quality of care programming for the American Association for Physician Leadership (AAPL). He served on the NQF Task Force on Improving Population Health and the John M. Eisenberg Award Committee for The Joint Commission. He also is a founding member of the AAMC-IQ Steering Committee, the group charged with infusing the tenets of quality and safety into medical education.
Dr. Nash has governance responsibilities for organizations in the public and private sectors. He has chaired the Technical Advisory Group (TAG) of the Pennsylvania Health Care Cost Containment Council (HC4) for more than 25 years and he is widely recognized as a pioneer in the public reporting of outcomes. Dr. Nash has been a hospital trustee for 20 years. He served on the Board of Trustees of Catholic Healthcare Partners (now Mercy Partners), in Cincinnati, OH (1998–2008), where he was the inaugural chair of the board committee on Quality and Safety. He concluded his tenure (2009-2017) on the board of Main Line Health, a four-hospital system in suburban Philadelphia, PA, where he also chaired the board committee on Quality and Safety. He now serves on the board of the Geisinger Commonwealth School of Medicine (GCSOM). In 2019, he joined the AMGA Foundation Board in Arlington, VA. Finally, he joined the board of CAHME – the Commission on Accreditation of Healthcare Management Education in 2021.

In the for-profit sector, he very recently completed nearly a decade as a member of the Board of Directors for Humana, Inc., one of the nation’s largest publicly traded healthcare companies. In 2014 he joined the board of InfoMC, a leading information technology company in suburban Philadelphia. He is on the health care advisory board for Arsenal Capital Partners in NYC and just joined the board of MaxHealth, a portfolio company of Arsenal. In late 2018 he joined the board of ANI Pharmaceuticals, a publicly traded generic drug manufacturer, headquartered in Princeton, NJ. Finally, he is a board member of FOX Rehab, a portfolio company of Blue Wolf Capital.

Dr. Nash has received many awards in recognition of his achievements. He received the top recognition award from the Academy of Managed Care Pharmacy (1995), the Philadelphia Business Journal Healthcare Heroes Award (1997), and was named an honorary distinguished fellow of the American College of Physician Executives (now AAPL) in 1998. In 2006 he received the Elliot Stone Award for leadership in public accountability for health data from NAHDO. Wharton honored Dr. Nash in 2009 with the Wharton Healthcare Alumni Achievement Award and in 2012 with the Joseph Wharton Social Impact Award. Also in 2012, he received the Philadelphia Business Journal award for innovation in medical education. In 2021, he was honored as a top national communicator for his work with the Philadelphia Convention and Visitors Bureau and he received the Champion Award from the regional Health Information Exchange (HIE).

Dr. Nash’s work is well known through his many publications, public and virtual appearances, and online column on MedPage Today. He has authored more than 100 peer-reviewed articles and edited 25 books, including The Quality Book, Demand Better, and most recently his best selling book, How Covid Crashed the System: A Guide to Fixing American Healthcare. He was the inaugural Deputy Editor of Annals of Internal Medicine (1984-1989). Currently, he is Editor-in-Chief of the American Journal of Medical Quality and Population Health Management.
Dr. Nash received his BA in economics (Phi Beta Kappa) from Vassar College; his MD from the University of Rochester School of Medicine and Dentistry and his MBA in Health Administration (with honors) from the Wharton School at the University of Pennsylvania. While at Penn, he was a former Robert Wood Johnson Foundation Clinical Scholar and Medical Director of a nine-physician faculty group practice in general internal medicine. He has received honorary doctorates from Salus University in Philadelphia, GCSOM, and the University of Rochester. Dr. Nash has delivered a score of endowed and named lectures across the country and has given more than 15 commencement addresses.

Together, the Drs. Nash have endowed an eponymous annual prize, across all learners throughout Jefferson, in healthcare quality and safety (which debuted in October 2021). This prize is the first of its kind in the nation.